Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.042
Neutral
RSI(14)
48.495
Neutral
STOCH(KDJ)(9,3,3)
34.001
Sell
ATR(14)
0.327
Low Volatility
CCI(14)
-3.255
Neutral
Williams %R
49.770
Neutral
TRIX(12,20)
-0.084
Sell
StochRSI(14)
0.000
Sell
Search
CapsoVision Inc
CVAdd to Watchlist
6.580USD
-0.120-1.79%
Close 07-31 16:00（ET）Quotes delayed by 15 min
328.76MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-1.79%
5 Days
+1.39%
1 Month
-9.62%
6 Months
+20.29%
Year to Date
-38.45%
1 Year
+68.29%
Key Figures
6.670Open
6.720High
66.29KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.13%Turnover Ratio
6.700Prev. Close
6.540Low
280.91KTurnover
LossP/E Static
16.22P/B
0.00%Div Yield TTM
-140.51%ROA
15.37052wk High
0.85Volume Ratio
-19.90MNet Profit
49.84MShares
-1.0632EPS TTM
--Beta
--ROE
3.43452wk Low
2.69%Amplitude
47.60%Gross Margin
328.76MMarket Cap
0.21Reward/Risk
6.43%Risk Rate
TradingKey Stock Score of CapsoVision Inc
Currency: USD Updated: 2026-07-31Key Insights
CapsoVision Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 112 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very low.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 10.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
CapsoVision Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
CapsoVision Inc Highlights
StrengthsRisks
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 38.97% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 13.55M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 13.55M.
Fairly Valued
The company’s latest PE is -6.19, at a medium 3-year percentile range.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 2.69K shares of this stock.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
10.000
Target Price
+51.98%
Upside Space
CapsoVision Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
1
analysts
Buy
Current Rating
10.000
Target Price
+51.98%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
CapsoVision Inc
CV
1
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Indicators
Moving Average
Indicators
Value
Direction
MA5
6.628
Sell
MA10
6.691
Sell
MA20
6.454
Buy
MA50
6.765
Sell
MA100
6.669
Sell
MA200
6.613
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
CapsoVision Inc Info
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Ticker SymbolCV
CompanyCapsoVision Inc
CEOWang (Kang-Huai)
Websitehttps://www.capsovision.com/
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
-6.42%
+0.10%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
+0.41%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%Popular Instruments
52776.700
+398.700 (+0.76%)
28543.700
+382.800 (+1.36%)
7534.400
+59.300 (+0.79%)
14651.000
-98.000 (-0.66%)
63563.000
+711.000 (+1.13%)
6403.400
+38.000 (+0.60%)
79.040
-6.894 (-8.02%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4062.910
+21.480 (+0.53%)
FAQs
What is the current price of CapsoVision Inc (CV)?
The current price of CapsoVision Inc (CV) is 6.58.
What is the symbol of CapsoVision Inc?
The ticker symbol of CapsoVision Inc is CV.
What is the 52-week high of CapsoVision Inc?
The 52-week high of CapsoVision Inc is 15.37.
What is the 52-week low of CapsoVision Inc?
The 52-week low of CapsoVision Inc is 3.43.
What is the market capitalization of CapsoVision Inc?
The market capitalization of CapsoVision Inc is 328.76M.
Is CapsoVision Inc (CV) currently rated as Buy, Hold, or Sell?
According to analysts, CapsoVision Inc (CV) has an overall rating of Buy, with a price target of 10.00.
What is the Earnings Per Share (EPS TTM) of CapsoVision Inc (CV)?
The Earnings Per Share (EPS TTM) of CapsoVision Inc (CV) is -1.03.